
Excell Partners
Description
Excell Partners is a distinctive not-for-profit venture capital fund based in Rochester, New York, dedicated to fostering the growth of high-tech startups across Upstate New York. Their core mission revolves around identifying and nurturing early-stage companies that are developing and commercializing innovative technologies. This strategic focus aims to stimulate economic development and job creation within the region, positioning Excell Partners as a crucial catalyst for the local innovation ecosystem.
The fund primarily targets seed and early-stage companies, providing essential capital to promising ventures in sectors such as life sciences, advanced materials, clean energy, and information technology. Excell Partners typically deploys initial investments ranging from $100,000 to $500,000, with a clear potential for follow-on funding as companies achieve key milestones. They frequently engage in co-investment strategies, partnering with other venture capital firms, angel investors, and strategic partners to maximize the impact and reach of their capital.
Since its inception in 2003, Excell Partners has demonstrated a significant commitment to the Upstate New York tech landscape, having invested over $50 million into more than 100 high-tech companies. This substantial financial backing has played a pivotal role in enabling these portfolio companies to attract considerable additional capital. In fact, Excell's investments have helped their portfolio companies leverage over $500 million in follow-on funding from various sources, underscoring the fund's effectiveness in de-risking early-stage ventures and attracting broader investment.
Investor Profile
Excell Partners has backed more than 45 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 20% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Health Care, Biotechnology, Manufacturing.
- Typical check size: $100K – $500K.
Stage Focus
- Seed (60%)
- Series Unknown (22%)
- Series A (16%)
- Series D (2%)
Country Focus
- United States (98%)
- Israel (2%)
Industry Focus
- Health Care
- Biotechnology
- Manufacturing
- Medical
- Medical Device
- Energy
- Crowdfunding
- Non Profit
- Software
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.